China Cord Blood Corporation to Change Corporate Name to "Global Cord Blood Corporation"
HONG KONG, Feb. 7, 2018 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), leading cord blood banking operator inChina, today announced that the Board of Directors of the Company (the "Board") has approved seeking shareholder approval regarding the change of the Co...
Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation
HONG KONG, Jan. 31, 2018 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), a leading cord blood bank operator in China, today announced that Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) ("Nanjing Ying Peng"), via its su...
Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation
HONG KONG, Jan. 31, 2018 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), a leading cord blood bank operator inChina, today announced that Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) ("Nanjing Ying Peng"), via its su...
China Cord Blood Corporation Announces Results of 2017 Annual General Meeting
HONG KONG, Dec. 7, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2017 Annual Gener...
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018
HONG KONG, Nov. 21, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for ...
China Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2018 Financial Results
HONG KONG, Nov. 13, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the second quarter and first half fiscal year 2018 onMonday, November 20, 2017, after the market close. The Company will host a confer...
October 31, 2017 Open Letter from Jayhawk Capital to Sanpower Group regarding China Cord Blood Corp
NEW YORK, Oct. 31, 2017 /PRNewswire/ -- The following is an open letter sent October 31, 2017 from Jayhawk Capital to Sanpower Group regarding China Cord Blood Corp (NYSE: CO). As significant minority shareholders of China Cord Blood Corp (NYSE: CO), we want to congratulate Sanpower Group on the...
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2017
HONG KONG, Sept. 22, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 201...
China Cord Blood Corporation Announces Adoption of 10b5-1 Sales Plan
HONG KONG, Aug. 28, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that Magnum Opus Second (PTC) Limited, an entity holding ordinary shares on behalf of certain directors and members of senior management, has adopted a 10b5-1 sales plan to sell up to ...
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2018
* 1Q18 Added 22,523 New Subscribers * 1Q18 Revenues Up 29.6% YOY to RMB224.2 Million ($33.1 Million ) * 1Q18 Operating Income Reached RMB83.0 Million ($12.2 Million) * Conference Call to be Held on August 24, 2017 at 8:00 a.m. ET HONG KONG, Aug. 24, 2017 /PRNew...
China Cord Blood Corporation to Report First Quarter Fiscal 2018 Financial Results
HONG KONG, Aug. 17, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release its preliminary unaudited first quarter fiscal 2018 financial results onWednesday, August 23, 2017, after the market close. The Company will host a conferen...
July 26, 2017 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
NEW YORK, July 27, 2017 /PRNewswire/ -- The following is an open letter sent July 26, 2017 U.S. time to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital. We recommend the Board repurchase 30 million shares as an effective use of the excess cash on the balance shee...
China Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 26, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual R...
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2017
Added 20,566 New Subscribers in 4Q17 4Q17 Revenue Amounted to RMB202.0 Million ($29.3 Million) 4Q17 Operating Income Amounted to RMB56.3 Million ($8.2 Million) Conference Call to be Held on June 22, 2017 at 8:00 a.m. ET HONG KONG, June 22, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE:...
China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2017 Financial Results
Earnings Call Scheduled for 8:00 a.m. ET on June 22, 2017 HONG KONG, June 14, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release its preliminary unaudited financial results for thefourth quarter and full year of fiscal 2017 onW...
China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding "Going Private" Proposal
HONG KONG, April 13, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding...
China Cord Blood Corporation Receives Notification of Exercise of 7% Senior Convertible Notes
HONG KONG, April 6, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that the Company received notificati...
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017
- 3Q17 Added 19,712 New Subscribers - 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) - 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) - Conference Call to be Held on February 27, 2017 at 8:00 a.m. ET HONG KONG, Feb. 25, 2017 /PRNewswire/ -- China Cord Blood Corpora...
China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2017 Financial Results
HONG KONG, Feb. 17, 2017 /PRNewswire/ -- Earnings Call Scheduled for 8:00 a.m. ET on February 27, 2017 China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine months fiscal year 2017 onFriday, Februa...
China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement
HONG KONG, Jan. 4, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the Company has been informed that G...
